University of Michigan researchers said head and neck cancer patients more than doubled their risk of death, heart attack, congestive heart failure, unstable angina or stroke if they failed to restart statin medications after surgery. They said reimbursement policies regarding restoration of these drugs are needed to ensure patients who need the medications have them when they leave the hospital.

Related Summaries